Clinical trial

Ocular Hypotensive Efficacy of AR-102

NCT00523250

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-09-01

PhasePHASE2

Study timeline

Study start (unknown)2007-09-01Date precision: month

Registry last updated2014-05-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

AR-102 0.003% Ophthalmic SolutionDRUG

AR-102 0.005% Ophthalmic SolutionDRUG

AR-102 0.01% Ophthalmic SolutionDRUG

AR-102 0.03% Ophthalmic SolutionDRUG

AR-102 Vehicle Ophthalmic SolutionDRUG

Sponsors & collaborators

Aerie Pharmaceuticalslead sponsor

Mapped research locations

San AntonioTexas, United States1 AustinTexas, United States1 CharlotteNorth Carolina, United States1 LouisvilleKentucky, United States1 PasadenaCalifornia, United States1 Rapid CitySouth Dakota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00523250 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.